In a review article published today in Advanced Healthcare Materials, NMIN trainees Dr. Miffy Hok Yan Cheng and Yulin Mo, together with NMIN researcher Dr. Gang Zheng, survey the latest… Read More »Nano versus Molecular: Optical Imaging Approaches to Detect and Monitor Tumor Hypoxia – a review by NMIN researcher & trainees
Three reviews by NMIN researchers – Drs Pieter Cullis, Shana Kelley, Dominik Witzigmann, and Gang Zheng – have been honoured with inclusion in 30th anniversary issues of the journal Bioconjugate… Read More »NMIN researchers featured in 30th anniversary issues of Bioconjugate Chemistry
Pfizer caught the world’s attention with its promising early results for a COVID-19 vaccine candidate. What has been less widely publicized is the pivotal role of Canadian know-how and technology… Read More »Canadian technology enables Pfizer’s promising COVID-19 vaccine
A new article by NMIN researchers published in the journal Nanoscale sheds light on a potential mechanism by which lipid nanoparticle (LNP) formulations of nucleic acid encapsulate short interfering RNA… Read More »NMIN research on entrapment of siRNA within LNPs published in Nanoscale
On September 17, 2020, Vancouver Nanomedicine Day was delivered for the first time entirely online. Event organizer Dr. Urs Häfeli, of the Faculty of Pharmaceutical Sciences at UBC, hosted the… Read More »NMIN features prominently in Vancouver Nanomedicine Day 2020
NMIN researcher Dr. Ellen Wasan and colleagues have been awarded a five-year CIHR Project Grant worth $745,876 to support and expand upon her NMIN-funded project, “Intranasal Vaccines for Pertussis and… Read More »Dr. Ellen Wasan receives a $745K CIHR grant to support her NMIN project
NMIN researcher Dr. Sarah Hedtrich, her team including NMIN Trainee Dr. Qurrat Ul Ain, and NanoCore`s Operational Lead Dr. Dominik Witzigmann, discuss the status of gene therapies as tools for… Read More »NMIN researchers discuss gene therapies for skin disease
NMIN researchers and colleagues have discovered a nanoparticle threshold dose that improves nanoparticle delivery and therapy for solid tumours. Published in Nature Materials, the study emerged from Dr. Warren Chan‘s… Read More »NMIN researchers discover dose threshold for nanoparticle tumour delivery
In a new review article in Human Gene Therapy, NMIN researcher Dr. Colin Ross and NMIN HQP Tiffany Carlaw and Lin-Hua Zhang provide an overview of the current state of… Read More »NMIN researchers discuss the current state of CRISPR/Cas9 editing
Using lipid nanoparticles (LNPs), NMIN research leaders Drs. Pieter Cullis and Christian Kastrup, together with colleagues at The University of British Columbia (UBC), have developed a new tool that can… Read More »NMIN researchers: A new nanomedicine treatment for thrombosis?